VTE risk assessment for hospitalized non-surgical patients
Primary source: Barbar S et al. J Thromb Haemost 2010; 8(11): 2450-2457
The Padua Prediction Score (Barbar S et al., J Thromb Haemost 2010) assesses the risk of venous thromboembolism (VTE) in hospitalized non-surgical patients. It includes 11 weighted parameters: active cancer (3), previous VTE (3), immobilization ≥ 3 days (3), known thrombophilia (3), trauma/surgery within the past month (2), age ≥ 70 years (1), heart/respiratory failure (1), acute myocardial infarction or ischemic stroke (1), acute infection/rheumatologic disease (1), BMI ≥ 30 (1), hormonal therapy (1).
Interpretation: a score ≥ 4 points indicates high VTE risk, and pharmacologic prophylaxis is recommended (low-molecular-weight heparin, fondaparinux, or mechanical compression if contraindicated). A score < 4 indicates low risk, and pharmacologic prophylaxis is generally not indicated.
The score is recommended by the ACCP 9th Edition (2012) and the ESC 2019 Guidelines on Acute Pulmonary Embolism as the standard risk stratification tool for non-surgical inpatients. An alternative is the IMPROVE Score, which also accounts for bleeding risk.
A 78-year-old woman is admitted with pneumonia. Respiratory rate 26, requires bed rest. Obesity (BMI 33). NYHA class II heart failure.
Age ≥ 70 (1) + immobilization ≥ 3 days (3) + acute infection (1) + BMI ≥ 30 (1) + heart failure (1) = 7 points.
High VTE risk. Management: prophylactic-dose LMWH (enoxaparin 40 mg/day or dalteparin 5000 IU/day) until mobility is restored or discharge. Concurrently assess bleeding risk (history, creatinine clearance; if GFR < 30, dose adjustment or unfractionated heparin). If contraindicated, use compression stockings and/or intermittent pneumatic compression.
Validated scores and formulas with full interpretation, clinical examples and source references. Open access, no registration required.
65+ calculators · scores and formulas · interpretation with management notes